No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Melanoma in situ
Similar endpoints
↥List of similar endpoints to
Melanoma in situ
based on the number of shared cases.
Similar with more cases:
- Melanoma in situ
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7222 | 3947 | 3251 |
| Only index persons | 6903 | 3818 | 3085 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.11 | 0.09 |
| Only index persons | 0.13 | 0.14 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 69.96 | 68.92 | 71.19 |
| Only index persons | 69.72 | 68.59 | 71.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1355 | 685 | 670 |
| Unadjusted period prevalence (%) | 0.26 | 0.23 | 0.30 |
| Median age at first event (years) | 69.12 | 66.85 | 71.44 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1179
- Matched controls
- 11789
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
41.3
323.0
497
204
D03.5
ICD-10 Finland
Melanoma in situ of trunk
+∞
323.0
374
*
D03.31
ICD-10 Finland
Melanoma in situ in another or unspecified part of the face
+∞
323.0
305
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
36.3
323.0
482
220
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
16.0
256.4
454
443
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
418.1
239.7
233
7
D03.6
ICD-10 Finland
Melanoma in situ of upper limb, including shoulder
+∞
204.2
190
*
8720/2-C44.9
ICD-O-3
Melanoma in situ of skin, NOS
2431.5
203.1
191
*
L57.0
ICD-10 Finland
Actinic keratosis
12.1
203.0
408
492
D03.7
ICD-10 Finland
Melanoma in situ of lower limb, including hip
+∞
185.4
173
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
47.9
182.8
223
57
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
20.6
181.3
280
175
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
18.6
179.7
289
202
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
172.2
161
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
165.6
155
*
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
23.9
145.4
212
107
ZZR00
NOMESCO Finland
Flap of skin
106.4
145.2
157
17
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
18.6
142.4
227
149
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
491.3
135.0
132
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
6.3
128.6
400
882
TQW99
NOMESCO Finland
Other minor procedure on skin
13.8
115.5
208
180
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
113.4
107
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
110.1
104
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
392.0
109.2
108
*
S18
ICPC
Laceration/cut
3.9
106.2
740
3538
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
101.5
96
*
8742/2-C44.9
ICD-O-3
Lentigo maligna of skin, NOS
+∞
97.2
92
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
91.9
87
*
D03.9
ICD-10 Finland
Melanoma in situ, unspecified
+∞
84.4
80
*
130
Kela drug reimbursment
Malignant tumour
+∞
78.0
74
*
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
28.8
75.4
103
39
D03.4
ICD-10 Finland
Melanoma in situ of scalp and neck
+∞
74.8
71
*
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
18.4
74.3
117
70
115
Kela drug reimbursment
Breast cancer
+∞
71.6
68
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
22.1
71.0
105
52
S77
ICPC
Malignant neoplasm of skin
180.1
65.7
68
*
SPAT1153
SPAT
Removal of sutures
3.0
65.0
543
2612
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
64.1
61
*
L82
ICD-10 Finland
Seborrhoeic keratosis
3.8
63.8
321
1057
ZXC50
NOMESCO Finland
Cryotherapy
13.1
61.4
111
93
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
59.9
57
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
58.8
56
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
57.8
55
*
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
33.3
57.2
75
24
S82
ICPC
Naevus/mole
4.1
56.3
245
701
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
149.5
54.3
57
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
283.4
53.6
54
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
101.6
53.3
58
6
D06BB10
ATC
imiquimod; topical
7.5
52.3
129
189
116
Kela drug reimbursment
Prostate cancer
+∞
51.4
49
*
C43
ICD-10 Finland
Malignant melanoma of skin
+∞
50.4
48
*
WF002
NOMESCO Finland
Radical radiotherapy
181.1
50.3
52
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
24.3
48.5
69
30
H02AB02
ATC
dexamethasone; systemic
20.6
48.0
72
37
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
25.8
47.2
66
27
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
46.1
44
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
46.1
44
*
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
11.1
44.8
87
84
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
+∞
44.0
42
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
44.0
42
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
+∞
44.0
42
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
44.0
42
*
JN4BD
NOMESCO Finland
Extensive body CT
5.6
43.8
135
265
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
65.1
43.5
50
8
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
43.0
41
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
43.0
41
*
ZXC20
NOMESCO Finland
Use of chemical agents
14.7
42.4
72
52
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.6
42.2
84
85
A04AA02
ATC
granisetron; systemic, transdermal
116.8
42.0
45
*
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
421.6
41.4
41
*
XQ846
NOMESCO Finland
Digital dermatoscopy and registration of nevi
93.5
41.1
45
5
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
15.3
40.7
68
47
D03.30
ICD-10 Finland
Melanoma in situ on the lip
+∞
39.8
38
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
389.4
38.3
38
*
D22
ICD-10 Finland
Melanocytic naevi
6.9
37.2
96
149
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
36.6
361
1769
L02BG04
ATC
letrozole; oral
22.6
36.0
52
24
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
11.0
35.7
69
66
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
80.7
35.0
39
5
ZZA00
NOMESCO Finland
Split skin graft
7.7
35.0
83
114
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
34.5
33
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
34.5
33
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
8.3
34.3
78
100
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
67.1
34.2
39
6
WF003
NOMESCO Finland
Adjuvant radiotherapy
346.6
34.1
34
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.8
33.9
119
269
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
32.4
31
*
D03.2
ICD-10 Finland
Melanoma in situ of ear and external auricular canal
+∞
32.4
31
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
32.4
31
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
31.0
31.8
42
14
C43.51
ICD-10 Finland
Malignant melanoma of the trunk originating in lentigo maligna
+∞
31.4
30
*
Z2221
NOMESCO Finland
Medical doctor
2.3
31.3
373
1982
ZZA50
NOMESCO Finland
Full thickness skin graft
113.0
30.8
33
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.1
30.7
42
16
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
39.2
30.4
38
10
L02AE02
ATC
leuprorelin; implant, parenteral
28.2
30.3
41
15
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
30.3
29
*
L02BB03
ATC
bicalutamide; oral
+∞
29.3
28
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
29.3
28
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
29.3
28
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
298.9
28.9
29
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
28.3
317
1620
ZQZ00
NOMESCO Finland
Treatment of several skin areas
56.5
28.3
33
6
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
28.2
27
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
28.2
27
*
ZXC15
NOMESCO Finland
Use of photodynamic technique
14.8
28.1
47
33
S29
ICPC
Skin symptom/complaint other
2.5
27.9
255
1172
DHB00
NOMESCO Finland
Excision of lesion of external nose
36.0
27.5
35
10
8743/3-C44.9
ICD-O-3
Low cumulative sun damage melanoma of skin, NOS
+∞
27.2
26
*
XQ845
NOMESCO Finland
Dermatoscopy
14.0
26.9
46
34
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
28.5
26.8
36
13
XQ848
NOMESCO Finland
Dermatological photography
7.0
26.7
67
100
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
26.1
25
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
26.1
25
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
266.1
25.8
26
*
HA1AA
NOMESCO Finland
X-ray mammography
6.6
25.5
67
107
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
25.1
24
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
25.1
24
*
C43.30
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face without histology
+∞
25.1
24
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
25.1
24
*
C43.69
ICD-10 Finland
Malignant melanoma of the upper extremity including shoulder other or unspecified histology
+∞
25.1
24
*
C43.60
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder without histology
+∞
25.1
24
*
JN4AD
NOMESCO Finland
Body CT examination
5.0
25.1
83
176
WX110
NOMESCO Finland
Local anesthesy
1.9
25.0
777
5893
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
+∞
24.0
23
*
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
24.0
23
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.6
23.8
85
195
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
7.3
23.6
57
81
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
7.5
23.5
56
78
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
23.0
22
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
23.0
22
*
Y77
ICPC
Malignant neoplasm prostate
234.2
22.7
23
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
22.1
438
2785
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
21.9
21
*
D03.1
ICD-10 Finland
Melanoma in situ of eyelid, including canthus
+∞
21.9
21
*
8720/2-C44.5
ICD-O-3
Melanoma in situ of skin of trunk
+∞
21.9
21
*
L01BC06
ATC
capecitabine; oral
+∞
21.9
21
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
21.6
174
739
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
23.6
21.3
30
13
I78.1
ICD-10 Finland
Naevus, non-neoplastic
6.7
21.3
55
86
D03.8
ICD-10 Finland
Melanoma in situ of other sites
+∞
20.9
20
*
DAB00
NOMESCO Finland
Excision of lesion of auricle
19.9
20.9
31
16
L02BA01
ATC
tamoxifen; oral
78.2
20.7
23
*
C50
ICD-10 Finland
Malignant neoplasm of breast
213.5
20.6
21
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
213.5
20.6
21
*
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
20.5
20.4
30
15
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
8.1
20.4
46
59
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
19.8
19
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
19.8
19
*
ZXE00
NOMESCO Finland
One hour or less
1.8
19.6
467
3131
D22.4
ICD-10 Finland
Melanocytic naevi of scalp and neck
9.6
19.2
39
42
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
18.8
18
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
18.8
18
*
8720/3-C44.3
ICD-O-3
Malignant melanoma, NOS, of skin of other and unspecified parts of face
+∞
18.8
18
*
8090/3-C44.7
ICD-O-3
Basal cell carcinoma, NOS, of skin of lower limb and hip
+∞
18.8
18
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
18.8
18
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.6
18.7
48
75
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
192.8
18.6
19
*
A98
ICPC
Health maint/preventive medicine
2.8
18.4
1114
10141
NK6AN
NOMESCO Finland
Total body bone isotope imaging
44.7
18.3
22
5
S26
ICPC
Fear of cancer of skin
11.3
18.3
34
31
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.1
18.2
58
119
C44.91
ICD-10 Finland
Unspecified localization of basocellular carcinoma of the skin
53.4
18.0
21
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
17.7
17
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
17.7
17
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
17.7
17
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
17.7
17
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
182.5
17.6
18
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
17.4
454
3097
Z3231
NOMESCO Finland
Registered nurse
1.9
17.1
324
1991
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
64.3
16.8
19
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
16.8
531
3827
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
16.7
16
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
16.7
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
16.7
16
*
180
Kela drug reimbursment
Interferon alfa
+∞
16.7
16
*
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
+∞
16.7
16
*
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
16.7
16
*
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
6.6
16.4
42
66
J01DB01
ATC
cefalexin; oral
1.8
16.3
921
7832
WX002
NOMESCO Finland
Sedation and analgesia
1.9
16.2
261
1509
Z51.5
ICD-10 Finland
Palliative care
5.0
16.2
52
108
S21
ICPC
Skin texture symptom/complaint
2.2
16.0
178
884
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
15.7
15
*
C43.71
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip originating in lentigo maligna
+∞
15.7
15
*
8742/3-C44.9
ICD-O-3
Lentigo maligna melanoma of skin, NOS
+∞
15.7
15
*
C43.42
ICD-10 Finland
Malignant melanoma of the scalp and neck: 'superficial spreading' type
+∞
15.7
15
*
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
15.7
15
*
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
3.5
15.4
73
218
L03AA02
ATC
filgrastim; parenteral
38.6
15.4
19
5
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
15.2
210
1140
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
29.0
15.2
20
7
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
45.6
15.1
18
*
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
10.2
15.0
29
29
ZX090
NOMESCO Finland
Other technic of radiotherapy
57.4
14.8
17
*
N02BE01
ATC
paracetamol; systemic, rectal
1.9
14.7
987
8662
E0000UV
ATC
NA
1.7
14.7
437
3059
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
18.6
14.7
22
12
8743/3-C44.5
ICD-O-3
Low cumulative sun damage melanoma of skin of trunk
+∞
14.6
14
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
14.6
14
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
14.6
14
*
C43.32
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face 'superficial spreading' type
+∞
14.6
14
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
14.6
14
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
14.6
14
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
14.6
14
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
14.6
14
*
D03.0
ICD-10 Finland
Melanoma in situ of lip
+∞
14.6
14
*
C44.3
ICD-10 Finland
Malignant neoplasm: Skin of other and unspecified parts of face
151.7
14.5
15
*
X76
ICPC
Malignant neoplasm breast female
151.7
14.5
15
*
ZX080
NOMESCO Finland
Image guided radiotherapy
151.7
14.5
15
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
14.4
375
2527
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.6
14.3
106
427
A04AA01
ATC
ondansetron; systemic, rectal
5.0
14.1
45
93
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.1
13.8
75
249
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
20.3
13.8
20
10
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
+∞
13.6
13
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
13.6
13
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
13.6
13
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
13.6
13
*
C43.73
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip nodular
+∞
13.6
13
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
13.6
13
*
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
141.5
13.5
14
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
141.5
13.5
14
*
WF004
NOMESCO Finland
Palliative radiotherapy
141.5
13.5
14
*
XKD00
NOMESCO Finland
Uroflowmetry
1.9
13.2
207
1177
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
19.3
12.9
19
10
WZC30
NOMESCO Finland
Teaching
2.3
12.7
127
599
R4110
NOMESCO Finland
Physiotherapy
1.7
12.7
296
1917
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.5
12
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
12.5
12
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
12.5
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.5
12
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
12.5
12
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
131.3
12.5
13
*
D03
ICD-10 Finland
Melanoma in situ
131.3
12.5
13
*
TQW40
NOMESCO Finland
Remowal of suture of skin
2.6
12.2
90
360
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
27.0
12.1
16
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
47.1
11.9
14
*
A79
ICPC
Malignancy NOS
47.1
11.9
14
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
11.7
173
960
Z48.0
ICD-10 Finland
Attention to surgical dressings and sutures
3.3
11.7
58
181
WX402
NOMESCO Finland
General anaesthesia
2.0
11.6
153
811
A04AA55
ATC
palonosetron, combinations; systemic
+∞
11.5
11
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
11.5
11
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
11.5
11
*
8720/2-C44.6
ICD-O-3
Melanoma in situ of skin of upper limb and shoulder
+∞
11.5
11
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
11.5
11
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
11.5
11
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
11.5
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
11.5
11
*
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
13.8
11.5
19
14
C90.0
ICD-10 Finland
Multiple myeloma
121.1
11.4
12
*
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
11.4
270
1747
D06BX02
ATC
ingenol mebutate; topical
5.4
11.4
33
62
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.9
11.2
165
912
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.0
11.1
43
110
C44
ICD-10 Finland
Other malignant neoplasms of skin
43.7
10.9
13
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
10.9
187
1093
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
10.8
481
3656
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
21.7
10.7
15
7
JN4CD
NOMESCO Finland
Very extensive body CT
4.5
10.7
37
85
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
10.6
155
854
QCE99
NOMESCO Finland
Other excision or repair of lesion of skin of upper limb
14.3
10.5
17
12
C44.50
ICD-10 Finland
Malignant tumor of the skin on the torso without histology
110.9
10.4
11
*
8090/3-C44.1
ICD-O-3
Basal cell carcinoma, NOS, of eyelid
+∞
10.4
10
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
10.4
10
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
CBB50
NOMESCO Finland
Excision of lesion of eyelid and reconstruction using graft or flap
+∞
10.4
10
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
10.4
10
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
8720/2-C44.7
ICD-O-3
Melanoma in situ of skin of lower limb and hip
+∞
10.4
10
*
C43.40
ICD-10 Finland
Malignant melanoma of the scalp and neck without histology
+∞
10.4
10
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
10.4
10
*
S79
ICPC
Neoplasm skin benign/unspecified
4.7
10.3
34
74
ZXC96
NOMESCO Finland
Robot assisted procedure
10.7
10.3
19
18
D04.9
ICD-10 Finland
Carcinoma in situ: Skin, unspecified
19.0
10.3
15
8
S08
ICPC
Skin colour change
2.7
10.2
68
259
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.4
10.1
35
81
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
40.4
10.0
12
*
D23.9
ICD-10 Finland
Benign neoplasm: Skin, unspecified
4.1
9.9
37
92
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
12.3
9.9
17
14
B01AB05
ATC
enoxaparin; parenteral
1.6
9.9
321
2253
UKC02
NOMESCO Finland
Cystoscopy
1.8
9.7
187
1133
L02BG03
ATC
anastrozole; oral
55.4
9.7
11
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.1
9.5
51
170
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
100.8
9.4
10
*
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
30.3
9.4
12
*
C43.61
ICD-10 Finland
Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna
+∞
9.4
9
*
C43.63
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder nodular
+∞
9.4
9
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
9.4
9
*
C43.91
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin originating in lentigo maligna
+∞
9.4
9
*
8742/3-C44.3
ICD-O-3
Lentigo maligna melanoma of skin of other and unspecified parts of face
+∞
9.4
9
*
ZZS00
NOMESCO Finland
Rotation flap
+∞
9.4
9
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
Z31.5
ICD-10 Finland
Genetic counselling
3.4
9.4
43
128
TQW80
NOMESCO Finland
Local dermatologic skincare
3.4
9.3
44
134
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
7.3
9.2
21
29
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
13.8
9.2
15
11
B01AB10
ATC
tinzaparin; parenteral
2.6
9.1
65
257
Z3226
NOMESCO Finland
Physiotherapist
1.7
9.1
201
1266
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
11.6
9.1
16
14
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
9.1
282
1951
S15
ICPC
Foreign body in skin
2.3
9.0
79
351
WW200
SPAT
NA
0.3
8.8
23
672
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
10.8
8.8
16
15
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
10.8
8.8
16
15
PJA10
NOMESCO Finland
Exploration of lymph nodes
14.1
8.7
14
10
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
14.1
8.7
14
10
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
50.3
8.7
10
*
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
50.3
8.7
10
*
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
6.2
8.6
22
36
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.7
8.6
28
61
R31
ICD-10 Finland
Unspecified haematuria
2.0
8.6
113
599
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
16.4
8.6
13
8
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.1
8.5
93
455
XW000
NOMESCO Finland
Bone marrow biopsy
3.0
8.4
46
156
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
90.6
8.4
9
*
J01CA04
ATC
amoxicillin; systemic
1.5
8.4
841
7401
UJF30
NOMESCO Finland
Ileoscopy through colon
2.0
8.4
103
531
ZXA00
NOMESCO Finland
Right side
1.5
8.4
318
2303
L01XE23
ATC
[U] dabrafenib; oral
+∞
8.3
8
*
153
Kela drug reimbursment
Lenalidomid
+∞
8.3
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.3
8
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
8.3
8
*
C43.29
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology
+∞
8.3
8
*
C44.10
ICD-10 Finland
Malignant tumor of the skin of the eyelids including the corner of the eye without histology
+∞
8.3
8
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
8.3
8
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
8.3
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.3
8
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
8.3
8
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
8.3
8
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
8.3
8
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
8.3
8
*
C44.99
ICD-10 Finland
Unspecified localization of malignant tumor in skin other or unspecified histology
+∞
8.3
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.3
8
*
C44.40
ICD-10 Finland
Malignant tumor of the skin of the scalp and neck without histology
+∞
8.3
8
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
17.3
8.1
12
7
QAE99
SPAT
NA
8.5
7.8
16
19
D02AE01
ATC
carbamide; topical
2.2
7.8
79
377
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
7.7
60
251
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
45.3
7.7
9
*
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
7.7
251
1748
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
7.7
85
421
SPAT1211
SPAT
Application of soft bandage
1.9
7.6
107
580
L03AB05
ATC
interferon alfa-2b; parenteral
18.5
7.6
11
6
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
18.5
7.6
11
6
WX320
NOMESCO Finland
Spinalanesthesy
1.5
7.5
261
1847
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
4.5
7.5
25
57
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.2
7.4
70
324
ZXA05
NOMESCO Finland
Left side
1.5
7.4
293
2133
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
7.3
132
781
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
7.3
68
310
C44.00
ICD-10 Finland
Malignant tumor of the lip skin without histology
+∞
7.3
7
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
7.3
7
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
7.3
7
*
8720/3-C44.4
ICD-O-3
Malignant melanoma, NOS, of skin of scalp and neck
+∞
7.3
7
*
L02BG06
ATC
exemestane; oral
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
L04AX04
ATC
lenalidomide; oral
+∞
7.3
7
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
7.3
7
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
7.3
7
*
8742/2-C44.5
ICD-O-3
Lentigo maligna of skin of trunk
+∞
7.3
7
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
7.3
7
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
7.3
7
*
C43.20
ICD-10 Finland
Malignant melanoma of the outer ear and in the external ear canal without histology
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
7.3
7
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.3
7
*
8742/2-C44.3
ICD-O-3
Lentigo maligna of skin of other and unspecified parts of face
+∞
7.3
7
*
C43.3
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of other and unspecified parts of face
+∞
7.3
7
*
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.5
7.3
24
54
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
15.8
7.2
11
7
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
7.2
427
3361
TQW40
SPAT
NA
2.8
7.2
43
156
A99
ICPC
Disease/condition unspecnature/site
2.0
7.2
94
499
TKE00
NOMESCO Finland
Needle biopsy of prostate
3.0
7.2
38
128
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
30.2
7.2
9
*
L04AX01
ATC
azathioprine; systemic
2.7
7.1
46
174
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
12.1
7.1
12
10
A02BC02
ATC
pantoprazole; systemic
1.4
7.0
695
5988
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.3
6.9
33
103
S19
ICPC
Skin injury other
2.5
6.9
52
216
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.9
717
6218
B07.9
ICD-10 Finland
Verruca simplex
3.1
6.9
35
115
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
16.8
6.7
10
6
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
6.7
943
8617
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
22.6
6.7
9
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
7.9
6.6
14
18
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.6
445
3571
ZXC12
NOMESCO Finland
Pulse colorlaser
12.3
6.6
11
9
WW500
NOMESCO Finland
Blood transfusion
3.3
6.5
30
92
L04AA01
ATC
[U] ciclosporin; systemic
4.5
6.5
21
47
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
4.5
6.5
21
47
J01FA10
ATC
azithromycin; systemic
1.4
6.5
532
4413
F16
ICPC
Eyelid symptom/complaint
2.3
6.4
57
255
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
70.2
6.4
7
*
S52
ICPC
Skin, Exc/remov/biopsy/destruc/debrid/caut
70.2
6.4
7
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
70.2
6.4
7
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
70.2
6.4
7
*
J05AB11
ATC
valaciclovir; oral
1.7
6.4
129
792
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
14.4
6.4
10
7
D22.1
ICD-10 Finland
Melanocytic naevi of eyelid, including canthus
14.4
6.4
10
7
Z02.4
ICD-10 Finland
Examination for driving licence
1.4
6.3
310
2347
M01AH05
ATC
etoricoxib; oral
1.4
6.3
590
4992
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.3
6.3
12
13
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
6.3
106
617
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
18.1
6.3
9
5
D22.0
ICD-10 Finland
Melanocytic naevi of lip
18.1
6.3
9
5
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
6.3
6
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
6.3
6
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
6.3
6
*
WB303
NOMESCO Finland
Simple adjuvant therapy of malignancy with biomodifiers
+∞
6.3
6
*
8743/3-C44.7
ICD-O-3
Low cumulative sun damage melanoma of skin of lower limb and hip
+∞
6.3
6
*
C43.82
ICD-10 Finland
Overall malignant melanoma of the skin: 'superficial spreading' type
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
8070/3-C44.4
ICD-O-3
Squamous cell carcinoma, NOS, of skin of scalp and neck
+∞
6.3
6
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
6.3
6
*
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
+∞
6.3
6
*
C43.43
ICD-10 Finland
Malignant melanoma of the scalp and neck nodular
+∞
6.3
6
*
C43.41
ICD-10 Finland
Malignant melanoma of the scalp and neck originating in lentigo maligna
+∞
6.3
6
*
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
6.3
6
*
8720/3-C44.2
ICD-O-3
Malignant melanoma, NOS, of external ear
+∞
6.3
6
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
6.3
6
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
6.3
6
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
26.8
6.2
8
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
26.8
6.2
8
*
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.5
6.2
232
1662
G04CA01
ATC
alfuzosin; oral
1.7
6.2
141
896
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.0
6.1
32
108
N63
ICD-10 Finland
Unspecified lump in breast
2.5
6.1
44
180
JFB30
NOMESCO Finland
Right hemicolectomy
8.6
6.1
12
14
127
Kela drug reimbursment
Transplant complication
4.9
6.1
18
37
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.2
6.0
29
92
ZX112
NOMESCO Finland
Subcutaneous
6.7
6.0
14
21
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.2
6.0
21
51
D01BA02
ATC
terbinafine; oral; topical
1.4
6.0
272
2024
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
678
772
16.58
307.65
1.9
1.1
—
—
—
0
0
(4035726)
343
314
14.29
307.65
1.5
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1081
3375
11.89
307.65
4.4
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
206
433
5.43
94.77
1.4
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
267
1163
2.61
39.09
5.4
2.8
u/l
242.3
236.9
0.22
253
1079
(3044640) Blood type and Crossmatch panel - Blood
519
3059
2.13
37.29
2.6
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
174
635
3.00
35.51
3.8
1.4
ug/l
4.1
3.7
0.23
140
481
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1234
10313
3.20
35.31
19.5
13.0
ml/min/173m2
74.4
75.1
0.49
1057
8310
(42870588) Differential panel, method unspecified - Blood
565
3562
2.01
32.74
7.0
5.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
32
26
12.58
32.46
1.3
1.0
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
440
2553
2.07
31.96
4.4
3.5
%
85.7
85.5
0.05
427
2481
(3013650) Neutrophils [#/volume] in Blood by Automated count
810
5839
1.96
31.17
10.0
6.3
e9/l
4.0
4.4
6.24
669
5023
(40768793) Breast Pathology biopsy report
48
74
6.69
29.95
1.3
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
729
5146
1.90
29.06
6.5
5.1
mmol/l
1.2
1.2
1.29
654
4536
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
745
5315
1.89
28.53
6.9
3.7
umol/l
11.1
12.1
2.34
697
4957
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1046
8371
2.09
28.34
9.1
5.4
u/l
77.7
76.9
0.21
967
7705
(3015377) Calcium [Moles/volume] in Serum or Plasma
552
3620
1.89
27.08
4.2
2.1
mmol/l
2.3
2.4
0.72
455
2973
(3022096) Basophils/100 leukocytes in Blood
678
4763
1.85
26.57
7.5
5.7
%
0.7
0.7
0.05
612
4391
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
773
5682
1.84
25.88
6.8
5.5
mmol/l
1.2
1.2
0.95
640
4774
(3013115) Eosinophils [#/volume] in Blood
750
5484
1.82
25.33
7.3
5.6
e9/l
0.2
0.2
2.77
610
4771
(3001604) Monocytes [#/volume] in Blood
727
5280
1.81
24.97
7.1
5.4
e9/l
0.6
0.6
0.20
586
4510
(3006315) Basophils [#/volume] in Blood
730
5311
1.81
24.90
7.1
5.4
e9/l
0.0
0.0
0.30
591
4549
(3006504) Eosinophils/100 leukocytes in Blood
686
4900
1.81
24.87
7.4
5.7
%
2.7
2.9
1.71
619
4507
(3019069) Monocytes/100 leukocytes in Blood
688
4920
1.81
24.84
7.6
5.9
%
9.1
8.8
1.76
623
4549
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
392
2369
1.92
24.17
2.5
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
735
5402
1.79
23.81
7.1
5.4
e9/l
1.8
1.8
0.48
603
4699
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
20
12
16.90
23.76
1.3
1.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1241
10877
2.68
23.47
18.3
13.9
mg/l
22.3
24.3
1.34
1020
8539
(3002030) Lymphocytes/100 leukocytes in Blood
691
5012
1.77
23.19
7.6
5.8
%
26.7
26.8
0.10
625
4608
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
656
4711
1.76
22.59
4.2
3.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
505
3364
1.80
22.51
3.9
3.1
e6/l
56.7
101.1
0.86
397
2584
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1296
11664
3.55
22.48
13.2
9.4
u/l
24.4
24.8
0.49
1238
11101
(3031040) Bacteria [#/volume] in Urine by Automated count
926
7356
1.82
22.37
5.0
4.7
e6/l
2863.2
2636.5
0.03
17
111
(3018010) Neutrophils/100 leukocytes in Blood
681
4965
1.75
22.04
7.3
5.6
%
58.3
58.1
0.13
620
4590
(3018095) Leukocytes [#/volume] in Urine
567
3929
1.76
21.92
4.6
3.6
e6/l
93.0
117.2
0.41
412
2781
(3024561) Albumin [Mass/volume] in Serum or Plasma
652
4720
1.74
21.44
5.3
3.7
g/l
35.4
35.3
0.35
597
4331
(3010813) Leukocytes [#/volume] in Blood
1318
12044
4.45
21.15
27.8
20.6
e9/l
6.7
6.8
1.32
1281
11597
(36304419) Bacteria [Presence] in Urine
454
2975
1.79
21.09
3.8
3.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1317
12038
4.35
20.92
27.8
20.5
e9/l
243.6
244.1
0.12
1283
11643
(3024731) MCV [Entitic volume]
1317
12041
4.34
20.85
27.7
20.5
fl
91.6
91.6
0.01
1295
11799
(3035941) MCH [Entitic mass]
1317
12042
4.34
20.83
27.7
20.4
pg
30.4
30.4
0.47
1295
11800
(3026361) Erythrocytes [#/volume] in Blood
1317
12043
4.34
20.80
27.8
20.5
e12/l
4.4
4.5
0.30
1278
11596
(3000963) Hemoglobin [Mass/volume] in Blood
1317
12045
4.33
20.76
27.9
20.7
g/l
134.1
135.0
1.44
1295
11803
(3021589) Normoblasts [#/volume] in Blood
647
4703
1.72
20.73
12.5
8.9
e9/l
0.0
0.0
0.16
505
3839
(3030467) Casts [#/volume] in Urine by Automated count
463
3074
1.77
20.43
3.9
3.1
e6/l
0.5
0.4
0.20
359
2328
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
299
1736
1.93
20.34
3.4
2.8
e6/l
1.6
2.5
1.33
169
946
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
379
2397
1.81
19.57
3.8
2.7
ug/l
0.8
0.8
0.76
271
1682
(3035637) Corticotropin [Mass/volume] in Plasma
42
86
5.01
19.53
1.4
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
486
3305
1.73
19.51
5.4
3.3
ph
7.4
7.4
0.79
105
591
(3023103) Potassium [Moles/volume] in Serum or Plasma
1279
11610
2.81
18.23
22.3
17.1
mmol/l
4.0
4.0
2.90
1247
11267
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
55
150
3.78
17.76
1.3
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1275
11581
2.71
17.68
21.8
17.0
mmol/l
139.7
139.7
0.16
1244
11250
(40758558) Short blood count panel - Blood
377
2462
1.74
17.07
7.4
4.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1248
11258
2.37
17.00
5.7
5.5
mmol/l
2.6
2.6
0.04
1110
10215
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1226
10986
2.22
16.87
5.0
4.8
mmol/l
4.5
4.5
0.00
1094
10017
(3022145) Colonoscopy Study observation
195
1042
2.02
16.62
1.4
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1244
11266
2.27
15.77
17.0
13.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1213
10881
2.10
15.74
5.1
4.8
mmol/l
1.5
1.5
1.32
1076
9847
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
15
0
+∞
15.65
1.0
0.0
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1092
9499
1.77
15.21
21.2
15.6
%
39.3
39.1
0.40
738
6032
(3032080) INR in Blood by Coagulation assay
628
4776
1.59
15.17
11.1
10.8
inr
1.3
1.4
1.42
187
1368
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1155
10220
1.88
15.15
5.7
4.7
mu/l
1.9
2.1
0.97
1023
9192
(3037467) Urinalysis macro (dipstick) panel - Urine
924
7713
1.62
14.85
4.8
4.4
—
—
—
0
0
(3026782) Osmolality of Urine
339
2226
1.70
14.73
3.1
2.6
mosm/kgh2o
575.6
542.8
2.24
291
1860
(3019420) Tryptase [Mass/volume] in Serum or Plasma
27
48
5.72
14.64
2.2
1.6
ug/l
15.6
13.7
0.08
27
37
(3026493) Urate [Moles/volume] in Serum or Plasma
432
3024
1.63
14.63
2.9
2.5
umol/l
5185.1
7221.1
0.35
362
2557
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1178
10519
1.92
14.60
4.5
4.3
mmol/l
1.3
1.3
0.17
1036
9427
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
296
1883
1.73
14.40
3.3
2.7
e6/l
0.9
1.5
1.38
166
1090
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1220
11041
2.05
14.28
5.5
5.0
mmol/l
6.0
6.1
1.99
1074
9903
(40768800) Prostate Pathology biopsy report
33
73
4.61
14.04
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1179
10576
1.88
13.76
6.6
6.6
mmol/mol
39.7
40.7
3.89
1055
9693
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
604
4623
1.55
13.74
2.3
2.2
nmol/l
83.4
79.0
3.36
517
4017
(3013707) Erythrocyte sedimentation rate by Westergren method
977
8333
1.62
13.72
4.7
4.3
mm/h
12.6
12.8
0.14
884
7640
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
984
8434
1.61
13.27
4.5
3.9
pmol/l
15.1
15.0
0.50
844
7559
(3000494) Fungus identified in Specimen by Culture
213
1262
1.82
13.13
1.4
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
323
2153
1.66
13.05
4.1
2.2
mmol/l
2.5
2.5
0.36
283
1845
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
561
4286
1.53
12.51
6.2
4.0
ug/l
5.0
3.0
0.51
475
3827
(3000850) Epithelial cells [#/volume] in Urine
345
2379
1.60
12.03
3.0
2.5
e6/l
4.1
5.4
1.50
309
2064
(3012095) Magnesium [Moles/volume] in Serum or Plasma
253
1620
1.69
11.80
3.1
2.5
mmol/l
0.8
0.8
0.59
227
1488
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
75
313
2.48
11.65
3.7
1.6
u/ml
31.6
25.6
0.28
69
299
(3049717) Cytology report of Urine Cyto stain
87
389
2.32
11.61
2.6
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
112
556
2.11
11.57
2.2
2.1
nmol/l
11.6
14.5
3.37
97
484
(3013512) EKG study
479
3597
1.51
11.29
4.1
4.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
34
92
3.77
11.16
1.7
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
60
230
2.68
11.09
3.6
1.9
u/ml
1869.9
66.1
0.49
51
180
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
784
6535
1.47
10.78
3.2
2.9
u/l
43.9
49.8
1.72
699
5934
(3013826) Glucose [Moles/volume] in Serum or Plasma
794
6652
1.47
10.51
4.9
4.4
mmol/l
6.6
6.9
3.95
760
6221
(3020630) Protein [Mass/volume] in Serum or Plasma
171
1013
1.79
10.46
2.9
1.6
g/l
65.7
66.9
1.12
151
904
(3002385) Erythrocyte distribution width [Ratio]
998
8770
1.52
10.28
24.6
16.8
%
13.8
13.7
1.10
980
8535
(3009214) Lutropin [Units/volume] in Serum or Plasma
43
147
2.99
9.83
1.1
1.3
u/l
11.6
10.9
0.11
35
123
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
192
1199
1.70
9.73
3.4
3.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
54
211
2.62
9.64
1.7
1.5
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
643
5243
1.43
9.42
2.2
2.1
pmol/l
93.1
94.1
0.21
320
2645
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
175
1076
1.72
9.37
2.6
2.2
umol/l
7.0
8.5
0.63
149
931
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
161
972
1.74
9.20
3.7
3.6
ng/l
95.9
92.8
0.17
133
825
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
56
231
2.49
8.97
3.8
2.1
%
189.4
194.4
0.15
51
218
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
143
843
1.78
8.87
2.0
1.9
g/l
0.2
0.2
3.49
133
757
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
21
47
4.52
8.85
1.5
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
410
3106
1.46
8.79
1.6
1.6
nmol/l
21.4
20.5
0.51
327
2579
(3036481) Cortisol [Moles/volume] in Serum or Plasma
157
954
1.73
8.76
3.7
1.8
nmol/l
412.0
361.4
1.12
147
856
(3001122) Ferritin [Mass/volume] in Serum or Plasma
556
4463
1.42
8.66
3.2
2.8
ug/l
144.1
131.0
0.74
491
4052
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
149
897
1.74
8.59
2.3
2.1
u/l
30.7
36.0
1.11
127
737
(3045142) Bone marrow Pathology biopsy report
27
76
3.60
8.42
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
147
887
1.74
8.41
4.6
4.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
83
416
2.06
8.39
3.0
1.4
g/l
1.2
0.5
0.99
64
352
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
228
1542
1.58
8.35
5.3
5.0
%
34.1
33.4
0.38
144
1008
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
669
5579
1.39
8.19
2.3
2.5
—
—
—
0
0
(3036489) Thrombin time
73
354
2.12
8.06
2.8
1.8
s
22.0
21.3
0.55
68
314
(3018677) aPTT in Platelet poor plasma by Coagulation assay
250
1753
1.52
7.75
2.5
1.9
s
30.5
29.9
0.74
242
1692
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
74
367
2.08
7.71
2.3
1.4
g/l
0.0
0.0
0.21
61
335
(3007853) Bacteria identified in Skin by Aerobe culture
191
1262
1.60
7.70
1.7
1.8
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
58
262
2.27
7.63
3.2
1.9
%
88.0
87.9
0.01
52
249
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
150
936
1.68
7.58
6.4
3.0
mmol/l
1.2
1.2
0.26
130
791
(3027945) Reticulocytes/100 erythrocytes in Blood
208
1409
1.56
7.53
2.8
2.1
%
1.8
1.8
0.17
177
1231
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
71
351
2.08
7.47
2.3
1.4
g/l
0.0
0.0
0.00
58
320
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
78
403
1.99
7.29
2.2
1.4
g/l
37.1
37.3
0.08
62
333
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
476
3837
1.37
6.80
2.2
2.2
u/l
210.2
238.6
0.25
441
3585
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
437
3483
1.38
6.67
4.7
3.9
%
21.6
24.1
3.07
229
1743
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
60
291
2.11
6.66
1.5
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
9
12.31
6.58
5.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
218
1537
1.50
6.52
1.9
2.0
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
463
1.87
6.51
2.4
1.4
g/l
3.1
3.1
0.01
63
362
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
67
346
1.99
6.30
2.4
1.4
g/l
0.0
0.0
0.00
57
318
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
500
1.81
6.20
2.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
500
1.81
6.20
2.3
1.4
g/l
3.6
3.9
1.25
63
358
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
500
1.81
6.20
2.3
1.4
g/l
7.3
7.5
0.50
66
367
(3023520) Reticulocytes [#/volume] in Blood
159
1060
1.57
6.15
2.9
2.2
e9/l
66.1
68.5
0.39
101
824
(3003458) Phosphate [Moles/volume] in Serum or Plasma
208
1470
1.49
6.14
7.9
4.8
mmol/l
1.0
1.0
0.12
195
1340
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
84
473
1.83
6.10
2.1
1.4
g/l
10.7
10.6
0.11
67
393
(3019225) pH of Specimen
174
1187
1.53
6.07
4.2
3.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
122
768
1.65
5.98
1.8
1.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
6
15.08
5.90
1.1
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
40
4.04
5.90
2.6
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
31
119
2.64
5.83
1.7
1.6
e6/l
101392.6
79768.2
0.12
17
68
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
400
3202
1.35
5.79
2.9
2.6
u/l
46.4
35.1
0.36
372
3031
(3012441) Differential panel - Pleural fluid
29
109
2.70
5.68
1.7
1.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
32
127
2.56
5.64
1.7
1.6
e6/l
1643.1
1689.4
0.03
20
88
(3044889) 12 lead EKG panel
891
8010
1.33
5.64
4.5
4.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
134
877
1.59
5.61
3.1
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
259
1942
1.41
5.57
1.9
1.8
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
59
305
1.98
5.56
3.2
3.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
43
197
2.22
5.55
1.1
1.2
iu/l
28.4
30.3
0.15
35
175
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
208
1500
1.46
5.52
3.4
2.6
%
23.3
22.4
0.47
191
1259
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
53
266
2.03
5.43
5.1
2.5
mg/l
1.9
1.7
0.94
48
235
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
358
1.89
5.42
3.4
2.8
u/ml
0.4
0.4
0.12
39
209
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
388
3121
1.34
5.37
1.6
1.6
mmol/l
1.3
1.4
0.23
301
2575
(3023368) Bacteria identified in Blood by Culture
383
3079
1.34
5.32
5.4
4.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
186
2545
0.69
5.27
4.3
4.2
kg/l
1.0
1.0
0.03
28
384
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
372
2984
1.34
5.23
2.3
2.2
mg/l
2.8
3.0
0.86
296
2517
(40768441) Liver Pathology biopsy report
16
44
3.67
5.21
1.3
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
136
910
1.55
5.18
1.8
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
41
191
2.18
5.10
3.8
3.4
%
61.2
58.5
0.90
41
191
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
185
2.20
5.07
3.4
3.2
e9/l
4.3
4.4
0.09
40
185
(40768797) Stomach Pathology biopsy report
207
1516
1.43
5.05
1.4
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
124
818
1.57
5.03
1.9
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
49
247
2.02
4.98
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
49
247
2.02
4.98
1.3
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
91
560
1.67
4.90
2.2
1.6
g/l
1.4
1.5
0.40
74
478
(3003694) ABO and Rh group [Type] in Blood
322
2556
1.34
4.81
1.4
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
67
383
1.79
4.69
5.2
1.5
mg/l
57.2
46.2
0.60
53
307
(3004789) Transferrin [Mass/volume] in Serum or Plasma
216
1617
1.40
4.65
3.3
2.5
g/l
2.2
2.3
0.92
199
1494
(3020779) Urea [Moles/volume] in Serum or Plasma
144
999
1.49
4.65
10.8
6.0
mmol/l
11.8
11.0
0.47
139
940
(40760892) CBC W Ordered Manual Differential panel - Blood
278
2175
1.35
4.55
5.2
4.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
66
382
1.77
4.45
5.2
1.5
mg/l
52.3
49.1
0.07
52
307
(3021879) Hepatitis B virus core Ab [Presence] in Serum
79
484
1.67
4.35
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
64
372
1.76
4.26
2.3
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
153
1094
1.45
4.25
1.8
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
132
917
1.49
4.24
7.8
7.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
28
122
2.32
4.12
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
104
696
1.54
4.00
3.6
2.3
g/l
10.7
10.9
0.10
96
632
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
290
2324
1.32
3.99
2.3
1.6
mg/l
1.9
1.3
0.42
220
1798
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
18
64
2.84
3.96
1.7
1.2
ug/l
19.2
15.8
0.27
18
64
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
84
537
1.60
3.94
3.3
3.0
pmol/l
4.2
4.5
2.17
73
461
(3051611) Lipemic interference index of Serum or Plasma
23
94
2.47
3.89
3.6
3.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
16
55
2.93
3.74
2.3
2.1
e9/l
0.9
1.2
—
10
30
(3035350) Ketones [Presence] in Urine by Test strip
614
5426
1.24
3.73
3.7
3.8
estimate
0.0
0.0
0.00
132
984
(4281824)
15
50
3.02
3.69
1.1
1.1
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
227
1777
1.33
3.67
3.2
2.4
umol/l
12.7
12.7
0.02
207
1630
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
85
555
1.57
3.66
3.8
3.6
mmol/l
24.5
24.3
0.36
79
484
(3021601) Nitrite [Presence] in Urine by Test strip
615
5452
1.23
3.58
5.0
5.1
estimate
0.0
0.0
0.50
136
982
(3026008) Bacteria identified in Urine by Culture
425
3620
1.25
3.56
3.2
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
24
106
2.29
3.46
1.8
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
621
5529
1.23
3.42
3.7
3.8
estimate
0.0
0.0
1.08
135
961
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
154
2.04
3.37
1.9
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
180
1379
1.35
3.36
1.9
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
27
3.72
3.35
1.9
2.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
20
439
0.45
3.33
2.3
3.7
mmol/l
1.9
1.4
0.73
20
431
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
402
3425
1.25
3.32
2.9
2.3
u/l
58.6
59.4
0.09
354
3130
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
32
162
2.00
3.31
1.2
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
92
628
1.50
3.27
1.3
1.3
au/ml
95.9
60.5
—
5
21
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
7
8.60
3.26
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
43
3.04
3.25
1.5
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
49
287
1.73
3.25
1.7
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
21
91
2.33
3.18
2.6
1.9
%
10.0
10.6
0.26
21
91
(3045424) Erythrocytes [Presence] in Urine
31
159
1.97
3.11
1.6
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
394
3372
1.24
3.10
3.3
3.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
39
3.10
3.09
2.7
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
59
371
1.62
3.02
3.0
2.4
g/l
0.3
0.3
0.11
24
115
(3016018) Differential panel - Cerebral spinal fluid
22
101
2.20
2.94
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
119
872
1.40
2.94
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
77
519
1.51
2.93
1.3
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
46
2.84
2.92
3.2
3.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
13
5.41
2.87
1.3
3.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
9
6.69
2.87
3.8
5.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
47
283
1.68
2.85
6.0
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
110
2.11
2.79
2.8
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
42
247
1.72
2.78
4.1
3.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
175
1376
1.31
2.75
1.9
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
331
2814
1.23
2.73
3.4
3.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
48
2.72
2.72
1.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
27
139
1.96
2.71
2.8
3.9
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
43
2.81
2.65
2.6
2.2
%
19.2
12.6
—
5
21
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
12
43
2.81
2.65
5.4
1.1
u/ml
14.2
57.4
—
5
11
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
449
3948
1.21
2.64
3.0
3.0
ng/l
2419.1
1600.3
0.89
383
3394
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
15
4.68
2.60
1.1
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
128
971
1.35
2.58
1.6
1.7
%
1.6
1.5
0.23
105
817
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
5
7
7.17
2.55
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
38
224
1.72
2.52
2.4
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
39
633
0.60
2.52
3.6
2.7
mmol/l
25.5
25.2
0.29
39
610
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
23
115
2.02
2.51
1.8
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
66
448
1.50
2.47
1.5
1.9
u/l
36.2
38.3
0.31
57
379
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
26
137
1.92
2.46
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
451
3989
1.20
2.46
3.6
3.2
mmol/l
7.1
7.3
0.28
348
3337
(1175426) CD3 cells/100 lymphocytes in Blood
12
45
2.68
2.45
2.8
2.2
%
70.4
74.0
0.22
12
40
(3042631) Mycobacterium sp identified in Specimen
27
145
1.88
2.43
2.4
2.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
23
117
1.98
2.41
1.8
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
28
153
1.85
2.39
1.9
2.4
mg/l
40.6
22.9
—
5
32
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
38
228
1.69
2.38
1.4
1.8
iu/l
3.8
4.0
—
10
79
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
8
6.27
2.37
1.8
1.3
—
—
—
0
0
(3015736) pH of Urine
478
4261
1.19
2.37
3.3
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
67
461
1.48
2.36
1.6
1.7
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
13
52
2.51
2.36
1.2
1.1
u/l
52.7
17.8
0.70
13
45
(3028026) IgM [Mass/volume] in Serum or Plasma
78
555
1.43
2.32
3.0
1.4
g/l
1.2
1.2
0.01
73
501
(3024928) Oxygen saturation in Venous blood
42
261
1.63
2.32
2.7
2.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
87
632
1.40
2.31
2.7
2.5
—
—
—
0
0
(1002224) Polysomnography panel
50
325
1.56
2.30
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
13
4.63
2.27
1.0
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
13
4.63
2.27
1.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
13
4.63
2.27
1.7
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
104
781
1.36
2.26
4.5
3.9
%
0.0
0.6
0.51
29
155
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
106
2.00
2.26
2.0
1.5
—
—
—
0
0
(4034850)
22
404
0.54
2.26
7.7
10.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
108
818
1.35
2.23
4.5
3.9
%
0.2
0.1
0.67
32
175
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
48
2.51
2.19
1.3
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
42
266
1.60
2.16
1.4
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
220
1836
1.24
2.15
2.0
1.3
g/l
2.6
2.7
0.10
126
1036
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
14
4.30
2.15
1.0
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
19
3.70
2.15
1.1
2.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
281
2405
1.21
2.15
4.2
4.1
ng/l
212.3
445.0
2.06
239
2034
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
159
1.78
2.14
1.2
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
104
789
1.34
2.13
4.1
3.7
%
0.7
0.6
0.12
26
146
(3025468) Yersinia sp identified in Specimen by Organism specific culture
22
116
1.91
2.11
1.8
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
8
25
3.21
2.09
1.0
1.1
%
104.5
109.7
—
8
20
(40768446) Kidney Pathology biopsy report
9
31
2.92
2.07
1.8
1.7
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
10
5.01
2.07
7.6
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
20
3.51
2.05
5.6
3.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
83
612
1.38
2.04
1.8
1.8
—
—
—
0
0
(3020891) Body temperature
30
490
0.60
2.04
3.0
4.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
16
76
2.12
2.03
1.0
1.2
mmol/l
2.0
2.0
0.14
16
70
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
79
579
1.39
2.02
7.1
9.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
26
3.09
2.01
1.9
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
26
3.09
2.01
1.9
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
26
3.09
2.01
1.9
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
38
2.64
2.01
1.2
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
38
2.64
2.01
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
436
3903
1.17
2.00
3.7
3.3
mg/l
371.5
237.0
0.24
267
2467
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
39
596
0.64
1.99
4.0
3.3
%
47.9
48.2
0.02
39
586
(3035880) pH of Pleural fluid
13
57
2.29
1.98
1.1
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
13
57
2.29
1.98
1.2
1.1
u/l
117.8
85.7
0.51
13
50
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
354
1.49
1.97
1.6
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
140
1122
1.28
1.95
1.9
2.1
ug/g
92.7
157.3
2.73
96
871
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
22
120
1.85
1.93
1.8
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
110
856
1.31
1.92
4.5
3.8
%
0.8
0.8
0.03
35
193
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
22
121
1.83
1.89
1.8
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
51
0.00
1.89
0.0
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
295
2567
1.19
1.88
1.8
1.8
nmol/l
1133.7
1177.6
0.29
181
1910
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
14
65
2.17
1.88
1.8
1.4
g/l
0.9
0.9
0.28
14
65
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
129
1.80
1.86
1.2
1.2
nmol/l
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
46
311
1.50
1.82
1.5
1.6
e6/l
7241.5
14534.0
1.13
23
234
(3014765) Yersinia sp identified in Stool by Organism specific culture
45
303
1.50
1.82
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
36
231
1.57
1.80
1.5
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
48
329
1.48
1.79
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
67
2.10
1.76
1.1
1.6
—
—
—
0
0
(4062490)
18
95
1.91
1.75
1.6
1.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
17
88
1.94
1.75
2.1
2.0
ug/l
2.8
3.1
0.22
17
81
(40765096) Chromosome analysis panel by Banding
6
18
3.34
1.74
1.0
1.0
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
45
306
1.49
1.74
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
79
595
1.35
1.74
1.3
1.2
iu/ml
63.9
125.9
1.31
17
240
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
44
298
1.49
1.74
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
36
2.51
1.74
1.8
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
36
2.51
1.74
1.8
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
36
2.51
1.74
1.8
1.2
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
36
2.51
1.74
1.8
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
210
1.59
1.72
1.9
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
34
218
1.57
1.72
1.8
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
36
234
1.55
1.72
1.2
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
18
96
1.89
1.71
1.6
1.4
g/l
7.2
7.1
—
10
71
(3028192) IgG subclass 2 [Mass/volume] in Serum
18
96
1.89
1.71
1.6
1.4
g/l
2.7
2.9
—
10
70
(3024139) IgG subclass 3 [Mass/volume] in Serum
18
96
1.89
1.71
1.6
1.4
g/l
0.4
0.4
—
10
70
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
23
133
1.74
1.70
1.9
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
35
227
1.56
1.69
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
67
495
1.37
1.67
1.7
2.0
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
21
119
1.78
1.66
1.1
1.0
g/l
1.5
1.5
0.62
21
103
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
7
25
2.81
1.65
1.3
1.3
%
27.6
27.4
—
7
19
(3023410) Appearance of Cerebral spinal fluid
20
112
1.80
1.65
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
97
760
1.30
1.64
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
222
1.55
1.60
1.7
1.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
211
1809
1.20
1.60
1.3
1.3
iu/ml
28.9
39.2
0.73
52
570
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
121
1.75
1.59
1.9
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
57
2.12
1.55
1.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
15
78
1.93
1.54
1.5
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
42
0.00
1.52
0.0
1.4
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
15
3.34
1.52
1.0
1.1
—
92.8
—
0
5
(3032057) Clostridioides difficile [Presence] in Stool
7
27
2.60
1.51
1.7
2.0
—
—
—
0
0
(4027681)
11
51
2.17
1.50
1.4
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
13
65
2.01
1.49
1.2
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
37
251
1.49
1.49
1.1
1.3
e6/l
14.3
698.0
0.97
28
211
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
37
251
1.49
1.49
1.1
1.3
e6/l
10.6
39.5
0.64
26
202
(3020682) Albumin/Creatinine [Ratio] in Urine
450
4118
1.14
1.46
4.8
4.0
mg/mmol
7.4
8.0
0.15
263
2583
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
28
2.51
1.45
1.6
1.7
—
—
—
0
0
(3004451) EKG impression Narrative
12
59
2.04
1.43
1.2
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
24
149
1.62
1.41
1.2
1.2
—
—
—
0
0
(3010421) pH of Blood
42
296
1.43
1.41
5.2
4.2
ph
7.4
7.4
0.32
35
242
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
29
2.42
1.39
3.0
2.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
88
698
1.28
1.39
8.1
8.3
%
94.5
93.3
1.55
88
693
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
58
435
1.35
1.36
1.5
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
248
1.46
1.36
2.4
2.5
%
15.2
16.5
1.27
22
127
(3035320) C reactive protein [Mass/volume] in Body fluid
14
75
1.88
1.34
3.1
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
291
1.42
1.33
1.3
1.4
ug/g
299.8
301.3
0.02
21
167
(3044941) Cell count panel - Synovial fluid
31
208
1.50
1.33
1.4
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
54
2.05
1.33
1.2
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
54
2.05
1.33
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
61
1.98
1.33
1.4
1.4
u/l
28.8
8.7
—
6
26
(3017732) Neutrophils [#/volume] in Blood
88
704
1.27
1.31
2.8
3.1
e9/l
4.0
4.2
0.43
52
495
(3021788) Differential panel - Synovial fluid
34
234
1.46
1.30
1.5
1.6
—
—
—
0
0
(3000012) Reticulocyte production index
12
62
1.94
1.28
1.1
1.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
88
707
1.26
1.27
8.1
8.1
%
1.1
1.4
2.64
88
701
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
87
698
1.26
1.27
8.0
8.2
%
0.6
0.7
0.82
87
692
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
35
244
1.45
1.26
1.4
1.4
—
—
—
0
0
(3012501) Base excess in Blood by calculation
35
244
1.45
1.26
5.1
4.5
mmol/l
2.0
3.0
0.66
24
163
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
14
77
1.83
1.25
1.4
1.7
umol/l
13.0
14.0
0.18
14
69
(3027456) Digoxin [Moles/volume] in Serum or Plasma
41
299
1.38
1.17
3.2
3.3
nmol/l
0.8
0.8
0.36
34
229
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
14
79
1.78
1.17
2.0
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
23
150
1.54
1.15
1.9
1.9
g/l
0.8
1.1
0.46
14
119
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
142
1.56
1.14
1.8
1.2
u/ml
267.4
253.7
0.09
12
81
(3009343) pH of Capillary blood
91
746
1.24
1.13
3.5
3.4
ph
7.4
7.4
0.08
16
97
(3029075) Extractable nuclear Ab panel - Serum
7
30
2.34
1.12
1.0
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
76
611
1.26
1.12
1.2
1.2
u/ml
122.6
237.0
1.08
69
561
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
127
1.58
1.11
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
720
1.24
1.11
3.5
3.3
mmol/l
1.4
1.8
0.73
61
521
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
21
2.39
1.09
1.4
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
8
41
1.96
1.09
16.6
2.8
mg/l
44.1
65.1
—
8
27
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
120
1.59
1.09
1.1
1.2
u/ml
2.7
7.5
—
6
57
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
41
304
1.36
1.08
1.6
1.6
iu/ml
0.1
0.1
—
10
68
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
32
2.19
1.08
4.3
2.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
17
264
0.64
1.04
1.1
1.1
—
9.5
—
0
24
(3006184) Hemoglobin [Mass/volume] in Capillary blood
37
272
1.37
1.03
2.3
2.1
g/l
125.6
132.5
0.83
30
203
(3024869) Neuronal Ab [Presence] in Serum
5
22
2.28
1.03
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
238
1.40
1.03
1.3
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
65
804
0.80
1.00
2.2
4.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
61
1.81
0.98
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
61
1.81
0.98
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
61
1.81
0.98
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
61
1.81
0.98
1.4
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
158
1384
1.16
0.98
1.4
1.3
titre
472.2
628.0
0.51
36
322
(3039443) Prostate specific Ag panel - Serum or Plasma
25
173
1.45
0.98
1.6
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
91
760
1.21
0.97
3.5
3.4
kpa
5.2
5.1
0.19
85
699
(40761535) Cells panel - Urine sediment
86
1029
0.82
0.97
3.8
3.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
100
1.61
0.97
1.7
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
142
1235
1.17
0.97
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
54
1.86
0.96
1.0
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
12
69
1.75
0.96
1.3
1.2
mmol/l
12.1
11.0
—
6
19
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
2.8
—
141.2
—
0
26
(3032773) Endomysium IgG Ab [Titer] in Serum
13
77
1.69
0.95
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
21
141
1.50
0.95
1.5
1.4
mu/l
35.6
52.0
0.35
15
124
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
51
1.77
0.94
3.3
4.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
55
436
1.27
0.94
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
200
1.41
0.94
7.9
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
67
545
1.24
0.93
3.7
3.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
28
2.15
0.91
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
501
4724
1.10
0.89
3.5
4.0
ng/l
36.2
77.5
1.66
369
3507
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.7
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.7
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
71
1.70
0.89
1.7
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
152
1.45
0.88
1.5
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
56
1.79
0.88
1.0
1.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
238
2162
1.12
0.87
1.2
1.2
u/ml
1.3
1.8
0.42
68
567
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
44
1.82
0.86
1.3
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
104
1.54
0.84
1.1
1.1
u/ml
0.3
1.1
—
7
38
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
20
137
1.47
0.84
2.0
1.3
u/ml
103.2
117.9
—
5
22
(1761482) Bacteria [#/volume] in Urine by Culture
24
331
0.72
0.83
3.7
4.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
57
462
1.24
0.83
3.9
3.7
mmol/l
25.2
24.7
0.57
50
424
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
121
1.49
0.83
1.2
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
17
114
1.50
0.79
1.0
1.4
mosm/kgh2o
274.9
274.9
0.00
12
82
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
8
48
1.67
0.78
1.0
1.0
—
7.8
—
0
5
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
66
1.67
0.78
2.5
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
90
1.56
0.78
1.8
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
13
82
1.59
0.78
1.0
1.1
nmol/l
3.9
13.7
—
5
16
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
105
1204
0.86
0.76
1.9
2.5
ug/l
7.3
7.6
0.05
89
1040
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
59
1.70
0.76
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
59
1.70
0.76
1.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.6
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
53
1.70
0.75
1.6
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
9
54
1.67
0.74
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
9
54
1.67
0.74
1.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
25
2.00
0.72
1.6
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
92
1.53
0.72
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
56
1.61
0.72
1.9
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
220
1.33
0.72
1.1
1.4
mmol/l
66.9
64.5
0.07
24
174
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
11
68
1.62
0.71
1.1
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
11
68
1.62
0.71
2.2
2.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
57
1.58
0.71
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
84
722
1.17
0.70
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
29
221
1.32
0.70
2.7
2.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
262
0.72
0.69
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
27
1.85
0.68
1.2
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
52
429
1.22
0.68
1.1
1.1
titre
—
173.4
—
0
12
(3044007) Cell count panel - Peritoneal fluid
5
28
1.79
0.66
1.0
2.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
11
70
1.58
0.65
2.2
2.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
258
0.73
0.64
1.3
1.6
—
—
—
0
0
(4010399)
96
843
1.15
0.63
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
323
0.77
0.61
1.6
1.7
mg/l
2.3
3.1
0.47
19
246
(3022217) INR in Platelet poor plasma by Coagulation assay
191
1754
1.10
0.61
37.4
29.3
inr
1.2
1.5
1.17
18
239
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
51
1.57
0.60
1.0
1.2
%
—
53.5
—
0
6
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
2.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
133
1198
1.12
0.60
2.4
3.0
ng/l
215.7
232.4
0.17
118
1110
(3000093) Morphology [Interpretation] in Blood Narrative
15
105
1.43
0.60
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
288
2700
1.08
0.59
3.6
3.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
28
219
1.28
0.58
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
219
1.28
0.58
1.8
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
27
343
0.78
0.58
3.2
2.3
ug/min
96.8
65.0
0.35
21
208
(3004616) Nuclear Ab [Presence] in Serum
20
149
1.35
0.58
1.5
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
158
1.33
0.57
2.1
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
132
1.37
0.57
1.2
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
17
124
1.38
0.56
1.9
2.0
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
6
37
1.62
0.55
1.0
1.1
ng/l
—
63.3
—
0
7
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
65
1.54
0.55
1.1
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
68
781
0.86
0.54
1.1
1.2
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
24
186
1.30
0.54
1.6
2.0
mmol/l
1.4
1.8
2.23
24
181
(3003396) Base excess in Arterial blood by calculation
146
1332
1.11
0.54
6.1
6.5
mmol/l
0.8
1.3
0.85
122
1020
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
99
1.42
0.54
2.3
2.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
61
1.48
0.53
1.2
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
9
61
1.48
0.53
4.0
4.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
62
1.45
0.53
2.4
2.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
91
1.43
0.53
2.8
3.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
91
1.43
0.53
1.1
1.0
u/ml
1.0
1.0
—
6
33
(3016879) Cocaine [Presence] in Urine
9
133
0.67
0.52
1.8
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
21
161
1.31
0.52
2.0
1.2
—
19.0
—
0
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
64
1.41
0.51
1.6
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
65
1.39
0.50
2.0
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
92
1.42
0.50
1.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
14
101
1.39
0.49
1.2
2.2
u/field
3.0
1.8
—
6
35
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
49
418
1.18
0.49
1.4
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
317
3006
1.07
0.49
4.3
4.1
estimate
0.0
0.0
0.69
132
950
(3039162) Centromere protein B Ab [Units/volume] in Serum
17
128
1.33
0.47
1.2
1.3
—
66.0
—
0
7
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
138
1266
1.10
0.47
1.5
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
174
1614
1.09
0.47
5.4
6.9
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
14
102
1.38
0.47
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
13
94
1.39
0.46
1.2
1.0
u/ml
3.3
2.6
—
7
39
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
29
237
1.23
0.45
1.1
1.2
—
60.0
—
0
6
(3000330) Specific gravity of Urine by Test strip
57
651
0.87
0.45
2.9
3.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
51
1.37
0.44
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
26
211
1.24
0.43
1.5
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
140
0.71
0.43
1.9
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
289
2747
1.07
0.42
1.7
1.7
pmol/l
45370797.7
19964540.1
0.24
216
2229
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
102
1119
0.90
0.42
1.7
1.6
—
—
—
0
0
(4306422)
16
122
1.32
0.42
1.3
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
5
32
1.56
0.42
1.0
2.5
—
6647.8
—
0
5
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
139
0.72
0.42
1.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.1
—
1.9
—
0
15
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
105
1.34
0.41
1.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
46
529
0.86
0.41
1.3
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
79
1.40
0.40
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
13
97
1.34
0.39
1.2
1.1
—
5.4
—
0
5
(4198724)
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(4211845)
9
68
1.33
0.37
4.0
4.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
13
169
0.77
0.37
2.8
2.2
mmol/l
107.0
105.4
0.65
13
169
(3041354) Potassium [Moles/volume] in Venous blood
13
169
0.77
0.37
2.8
2.2
mmol/l
4.0
4.1
0.21
13
169
(3002523) Influenza virus A Ag [Presence] in Specimen
11
81
1.36
0.36
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
78
0.64
0.35
1.4
1.3
promille
2.3
1.2
—
5
63
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
99
1.32
0.35
1.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
41
357
1.15
0.35
3.1
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
184
1737
1.07
0.35
1.3
1.3
u/ml
14.1
13.5
0.03
51
653
(4015189)
6
44
1.37
0.34
1.3
2.6
—
—
—
0
0
(4268621)
12
91
1.32
0.33
2.0
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
74
1.35
0.32
1.1
1.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
110
1.28
0.31
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
164
0.79
0.30
2.8
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
142
0.77
0.30
1.7
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
142
0.77
0.30
1.7
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
362
1.14
0.30
1.4
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
31
268
1.16
0.30
1.5
1.1
—
1816.3
—
0
8
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
111
1.26
0.30
2.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
55
1.27
0.30
1.1
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
55
1.27
0.30
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
141
0.78
0.29
1.7
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
109
0.73
0.29
1.9
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
57
1.23
0.29
1.1
1.5
—
—
—
0
0
(4146454)
18
149
1.21
0.28
2.3
2.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
66
1.21
0.26
1.8
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
123
1.22
0.25
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
74
1.22
0.25
1.8
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
142
1.20
0.24
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
78
1.28
0.24
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
78
1.28
0.24
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
78
1.28
0.24
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
147
0.81
0.23
1.8
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
17
143
1.19
0.23
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
38
1.32
0.23
1.2
1.3
ug/l
8.0
9.5
—
5
38
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
13
106
1.23
0.23
1.2
1.1
—
59.0
—
0
5
(3044927) Protein electrophoresis panel - Urine
19
162
1.18
0.23
1.9
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
39
1.28
0.23
1.2
1.1
miu/ml
861.2
1830.4
—
5
39
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
13
107
1.22
0.21
1.2
1.1
—
61.7
—
0
12
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
5
42
1.19
0.21
5.2
2.2
—
43.0
—
0
19
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806071)
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
10
0.00
0.21
0.0
14.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
80
1.25
0.20
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
80
1.25
0.20
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
80
1.25
0.20
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
231
1.13
0.19
1.3
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
186
0.86
0.19
1.4
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
60
1.17
0.17
1.1
1.4
nmol/l
111.6
146.6
—
7
60
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
163
0.86
0.17
1.6
1.5
%
43.4
65.2
—
7
104
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
51
475
1.08
0.17
1.9
1.7
ug/l
2.0
1.8
0.07
42
410
(3017704) Immunofixation for Urine
5
70
0.71
0.16
5.4
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
70
0.71
0.16
1.6
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
69
1.16
0.16
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
42
453
0.92
0.16
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
76
0.79
0.15
2.2
1.1
—
—
—
0
0
(4094501)
34
313
1.09
0.15
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
11
93
1.18
0.14
1.1
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
16
141
1.14
0.14
1.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
218
1.10
0.13
1.7
1.9
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
132
1.14
0.13
1.0
1.1
—
21.5
—
0
5
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
509
0.94
0.13
1.6
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
119
1150
1.04
0.13
3.7
3.2
mmol/l
2.0
2.0
0.04
105
918
(3014051) Protein [Presence] in Urine by Test strip
30
277
1.08
0.13
1.7
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
35
326
1.08
0.12
1.9
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
147
0.88
0.11
1.5
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
414
4197
0.98
0.11
4.0
4.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
16
178
0.90
0.11
1.3
1.2
miu/ml
171.8
222.3
—
5
74
(3019832) Treponema pallidum Ab [Presence] in Serum
47
445
1.06
0.11
1.6
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
86
1.16
0.11
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
46
1.09
0.09
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
52
499
1.04
0.08
1.6
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
137
1.10
0.07
1.9
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
8
76
1.05
0.07
1.0
11.2
—
—
—
0
0
(4024509)
11
122
0.90
0.07
1.3
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
46
444
1.04
0.06
1.4
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
242
0.95
0.05
1.6
1.6
nmol/l
0.7
0.8
0.16
18
196
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
92
936
0.98
0.04
2.8
2.4
ml/min/173m2
57.6
63.1
0.78
46
382
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
170
1.06
0.04
1.8
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
694
0.98
0.04
1.6
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
11
119
0.92
0.04
2.0
1.5
%
51.0
28.8
—
6
74
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
21
200
1.05
0.03
1.2
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
262
1.03
0.02
4.4
3.6
mg/l
32.8
28.0
0.20
15
171
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
17
177
0.96
0.01
1.5
1.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
79
784
1.01
0.00
2.7
3.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
129
1.01
0.00
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
171
0.99
0.00
2.4
2.7
—
—
—
0
0
(44790048)
11
107
1.03
0.00
1.6
1.5
—
—
—
0
0
(44790047)
11
107
1.03
0.00
1.6
1.5
—
—
—
0
0
(44806118)
11
107
1.03
0.00
1.6
1.5
—
—
—
0
0
(44790049)
11
107
1.03
0.00
1.6
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
177
1.02
0.00
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
50
1.00
0.00
4.8
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
81
0.99
0.00
1.5
1.6
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
55
0.91
0.00
1.0
1.3
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
12.9
—
0
6
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
6
63
0.95
0.00
1.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
5
0.00
0.00
0.0
2.4
—
633.0
—
0
5
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.6
—
402.8
—
0
9
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
51
0.98
0.00
1.0
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
76
0.92
0.00
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
9
0.00
0.00
0.0
1.9
—
2.0
—
0
9
(3017509) Phencyclidine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
120
1.00
0.00
1.3
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_MELANOMA_EXALLC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_INSITU_MELANOMA_EXALLC | 0.995 [0.86, 1.15] | 0.943 |
| Birth year | 0.994 [0.99, 1.0] | 0.188 |
During the follow-up period (1.1.1998 — 31.12.2019), 627 out of 3279 females with CD2_INSITU_MELANOMA_EXALLC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_INSITU_MELANOMA_EXALLC | 0.946 [0.8, 1.12] | 0.508 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 633 out of 2656 males with CD2_INSITU_MELANOMA_EXALLC died.
Mortality risk
Mortality risk for people of age
years, who have CD2_INSITU_MELANOMA_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.07% | 0.173% |
| 5 | 0.517% | 0.981% |
| 10 | 1.435% | 2.39% |
| 15 | 2.698% | 4.565% |
| 20 | 4.845% | 7.94% |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_MELANOMA_EXALLC – Melanoma in situ
GWS hits: 7
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data